Ethinyl Estradiol and Glecaprevir/Pibrentasvir Interaction

Drug interaction information between Ethinyl Estradiol and Glecaprevir/Pibrentasvir.

Ethinyl Estradiol and Glecaprevir/Pibrentasvir have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Ethinyl Estradiol and Glecaprevir/Pibrentasvir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Ethinyl Estradiol

Vaginal Contraceptive Ring

Drug B

Glecaprevir/Pibrentasvir

NS3/4A/NS5A Inhibitor (HCV)

How They Interact

Taking these medications at the same time can cause a rise in liver enzymes. This is often a sign that the liver is under stress or being irritated.

FDA Label Information

Concomitant use with some other HCV antiviral medicinal products, such as those containing glecaprevir/pibrentasvir, may increase the risk of ALT elevations [see Warnings and Precautions (5.4) ] .

Frequently Asked Questions

What SPL severity band is on file for Ethinyl Estradiol/Etonogestrel + Glecaprevir/Pibrentasvir?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Glecaprevir/Pibrentasvir has 38 labeled pairs on file vs Ethinyl Estradiol's 28. In the moderate band specifically: Ethinyl Estradiol has 1; Glecaprevir/Pibrentasvir has 9 (also Cyclosporine, Darunavir, Estradiol, Ethinyl Estradiol).

What mechanism field is on file for Ethinyl Estradiol/Etonogestrel and Glecaprevir/Pibrentasvir?

Taking these medications at the same time can cause a rise in liver enzymes. This is often a sign that the liver is under stress or being irritated.

Glecaprevir/Pibrentasvir carries more major-labeled pairs than Ethinyl Estradiol

SPL source-record counts only. This page's band is moderate · classes on file: Ethinyl Estradiol (Vaginal Contraceptive Ring); Glecaprevir/Pibrentasvir (NS3/4A/NS5A Inhibitor (HCV)).

Glecaprevir/Pibrentasvir has 3 major-labeled pairs vs Ethinyl Estradiol's 0. This page itself is in the moderate band, not the major band.

Ethinyl Estradiol

0 major · 1 moderate · 27 minor · 28 total

Ethinyl Estradiol has no other moderate-band peer in this dataset besides Glecaprevir/Pibrentasvir.

Glecaprevir/Pibrentasvir

3 major · 9 moderate · 26 minor · 38 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.